Journals / Turkish Journal of Medical Sciences / 2010 / Cilt: 40 - Sayı: 2

Cancer and ovarian tissue cryopreservation

Pages
159–168
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, technical details of ovarian tissue cryopreservation, related indications, and methods of ovarian tissue transplantation are discussed and an algorithmic approach to fertility preservation is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although ovarian tissue cryopreservation is still accepted as an experimental procedure, it has recently become an increasingly resorted technique in highly specialized in vitro fertilization (IVF) clinics.
📊
Key Findings & Data:There are 2 main methods for transplantation of frozen-thawed ovarian tissues: orthotopic and heterotopic transplantation.
💡
Conclusion & Impact:In this review, technical details of ovarian tissue cryopreservation, related indications, and methods of ovarian tissue transplantation are discussed and an algorithmic approach to fertility preservation is presented.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Key words: Ovarian cryopreservation · transplantation · fertility preservation

Abstract

Although ovarian tissue cryopreservation is still accepted as an experimental procedure, it has recently become an increasingly resorted technique in highly specialized in vitro fertilization (IVF) clinics. Its indications include many childhood cancers, breast cancer, some autoimmune diseases, hematopoietic stem cell transplantation, and pelvic radiation therapy due to solid tumors. The chemotherapeutics and radiation therapy may diminish ovarian reserve and cause premature ovarian failure. It currently seems as the only option for fertility preservation in children where ovulation induction is ethically not acceptable, and for those when cytotoxic therapy is urgent. There are 2 main methods for transplantation of frozen-thawed ovarian tissues: orthotopic and heterotopic transplantation. Together with its advantages, this method also has some risks, such as reimplantation of the primary tumor, malignant transformation, and loss of follicles. Therefore, a thorough counseling should be provided before going forward with the procedure. Although it is still an experimental method, there are 7 reports of live births after ovarian tissue cryopreservation. In this review, technical details of ovarian tissue cryopreservation, related indications, and methods of ovarian tissue transplantation are discussed and an algorithmic approach to fertility preservation is presented.

Özet

Although ovarian tissue cryopreservation is still accepted as an experimental procedure, it has recently become an increasingly resorted technique in highly specialized in vitro fertilization (IVF) clinics. Its indications include many childhood cancers, breast cancer, some autoimmune diseases, hematopoietic stem cell transplantation, and pelvic radiation therapy due to solid tumors. The chemotherapeutics and radiation therapy may diminish ovarian reserve and cause premature ovarian failure. It currently seems as the only option for fertility preservation in children where ovulation induction is ethically not acceptable, and for those when cytotoxic therapy is urgent. There are 2 main methods for transplantation of frozen-thawed ovarian tissues: orthotopic and heterotopic transplantation. Together with its advantages, this method also has some risks, such as reimplantation of the primary tumor, malignant transformation, and loss of follicles. Therefore, a thorough counseling should be provided before going forward with the procedure. Although it is still an experimental method, there are 7 reports of live births after ovarian tissue cryopreservation. In this review, technical details of ovarian tissue cryopreservation, related indications, and methods of ovarian tissue transplantation are discussed and an algorithmic approach to fertility preservation is presented.

🔖

Cite This Article

SÖNMEZER, M., ŞÜKÜR, Y. E., ÖZMEN, B. (2022). Cancer and ovarian tissue cryopreservation. Turkish Journal of Medical Sciences, Cilt: 40 - Sayı: 2, 159–168. https://ajindex.com/articles/611447

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008
  2. Hamzaoğlu O, Özcan U. Türkiye Sağlık İstatistikleri. Birinci baskı, Türk Tabipler Birliği 2006, p.60
  3. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics. CA Cancer J Clin 2004; 54: 8-29
  4. Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2004; 82: 993-8
  5. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004; 10: 251-66
  6. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788-93
  7. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 27: 535-43
  8. Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998; 27: 927- 43
  9. Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril 1997; 68: 724-6
  10. Polak de Fried E, Notrica J, Rubinstein M, Marazzi A, Gomez Gonzalez M. Pregnancy after human donor oocyte cryopreservation and thawing in association with intracytoplasmic sperm injection in a patient with ovarian failure. Fertil Steril 1998; 69: 555-7
  11. Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum Reprod 2004; 19: 477-80
  12. Sonmezer M, Shamonki MI, Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005; 322: 125-32
  13. Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1986;1:84-6
  14. Quintans CJ, Donaldson MJ, Bertolino MV, Pasqualini RS. Birth of two babies using oocytes that were cryopreserved in a choline-based freezing medium. Hum Reprod 2002; 17: 3149- 52
  15. Oktay K, Kan MT, Rosenwaks Z. Recent progress in oocyte and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol 2001; 13: 263-8
  16. Arndt CA, Donaldson SS, Anderson JR, Andrassy RJ, Laurie F, Link MP et al. What constitutes optimal therapy for patients with rhabdomyosarcoma